Für diesen Artikel ist leider kein Bild verfügbar.

Eliminating the Public Health Problem of Hepatitis B and C in the United States

Phase One Report
Buch | Softcover
186 Seiten
2016
National Academies Press (Verlag)
978-0-309-43799-8 (ISBN)
65,95 inkl. MwSt
Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide.



The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the first of two, examines the feasibility of hepatitis B and C elimination in the United States and identifies critical success factors. The phase two report will outline a strategy for meeting the elimination goals discussed in this report.

Table of Contents


Front Matter
Summary
1 Introduction
2 The Elimination of Hepatitis B
3 The Elimination of Hepatitis C
4 Conclusion
Appendix A: Committee Meeting 1 Agenda
Appendix B: Committee Meeting 2 Agenda
Appendix C: Committee Biographies
Appendix D: Glossary

1 Front Matter; 2 Summary; 3 1 Introduction; 4 2 The Elimination of Hepatitis B; 5 3 The Elimination of Hepatitis C; 6 4 Conclusion; 7 Appendix A: Committee Meeting 1 Agenda; 8 Appendix B: Committee Meeting 2 Agenda; 9 Appendix C: Committee Biographies; 10 Appendix D: Glossary

Erscheinungsdatum
Verlagsort Washington
Sprache englisch
Maße 152 x 229 mm
Themenwelt Studium Querschnittsbereiche Infektiologie / Immunologie
Studium Querschnittsbereiche Prävention / Gesundheitsförderung
ISBN-10 0-309-43799-7 / 0309437997
ISBN-13 978-0-309-43799-8 / 9780309437998
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Oliver Schmetzer

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Antibiotika, Virostatika, Antimykotika, Antiparasitäre Wirkstoffe

von Hans-Reinhard Brodt; Achim Hörauf; Michael Kresken …

Buch (2024)
Thieme (Verlag)
165,00